Impact on clinical practice of updated guidelines on iodinated contrast material: CINART

E. C. Nijssen*, P. J. Nelemans, R. J. Rennenberg, A. J. van der Molen, G. V. van Ommen, J. E. Wildberger

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objective Guidelines on safe use of iodinated contrast material recommend intravenous prophylactic hydration to prevent post-contrast adverse (renal) effects. Recently, guidelines have been updated and standard prophylaxis is no longer recommended for the majority of patients. The current study aims to evaluate the consequences for clinical practice of the updated guidelines in terms of complications, hospitalisations, and costs. Methods The Contrast-Induced Nephropathy After Reduction of the prophylaxis Threshold (CINART) project is a retrospective observational study. All elective procedures with intravascular iodinated contrast administration at Maastricht University Medical Centre (UMC+) in patients aged > 18 years, formerly eligible for prophylaxis (eGFR 30-44 ml/min/1.73 m(2) or eGFR 45-59 ml/min/1.73 m(2) in combination with diabetes or > 1 predefined risk factor), and currently eligible for prophylaxis (eGFR <30 ml/min/1.73 m(2)) were included. Data were used to calculate relative reductions in complications, hospitalisations, and costs associated with standard prophylactic intravenous hydration. CINART is registered with : NCT03227835. Results Between July 1, 2017, and July 1, 2018, 1992 elective procedures with intravascular iodinated contrast in patients formerly and currently eligible for prophylaxis were identified: 1808 in patients formerly eligible for prophylaxis and 184 in patients currently eligible for prophylaxis. At Maastricht UMC+, guideline updates led to large relative reductions in numbers of complications of prophylaxis (e.g. symptomatic heart failure; - 89%), extra hospitalisations (- 93%), and costs (- 91%). Conclusion Guideline updates have had a demonstrable impact on daily clinical practice benefiting patient, hospital, and health care budgets. Clinical practice varies between institutions and countries; therefore, a local estimation model is provided with which local impact on costs, hospitalisations, and complications can be calculated.

Original languageEnglish
Pages (from-to)4005-4013
Number of pages9
JournalEuropean Radiology
Volume30
Issue number7
DOIs
Publication statusPublished - Jul 2020

Keywords

  • Clinical practice guideline
  • Contrast media
  • Preventive measures
  • Acute kidney injury
  • Costs and cost analysis
  • ACUTE KIDNEY INJURY
  • RISK
  • PREVENTION
  • HYDRATION
  • MEDIA

Fingerprint

Dive into the research topics of 'Impact on clinical practice of updated guidelines on iodinated contrast material: CINART'. Together they form a unique fingerprint.

Cite this